CN102370731A - Medicament for treating prolapse of lumbar intervertebral disc, hyperosteogeny and hydrarthrosis and preparation method thereof - Google Patents
Medicament for treating prolapse of lumbar intervertebral disc, hyperosteogeny and hydrarthrosis and preparation method thereof Download PDFInfo
- Publication number
- CN102370731A CN102370731A CN2011103310398A CN201110331039A CN102370731A CN 102370731 A CN102370731 A CN 102370731A CN 2011103310398 A CN2011103310398 A CN 2011103310398A CN 201110331039 A CN201110331039 A CN 201110331039A CN 102370731 A CN102370731 A CN 102370731A
- Authority
- CN
- China
- Prior art keywords
- hyperosteogeny
- intervertebral disc
- parts
- lumbar intervertebral
- medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 55
- 206010005963 Bone formation increased Diseases 0.000 title claims abstract description 36
- 208000012287 Prolapse Diseases 0.000 title claims abstract description 36
- 238000002360 preparation method Methods 0.000 title claims abstract description 12
- 206010023215 Joint effusion Diseases 0.000 title abstract description 12
- 201000001819 hydrarthrosis Diseases 0.000 title abstract description 12
- 239000000203 mixture Substances 0.000 claims abstract description 15
- 239000000843 powder Substances 0.000 claims abstract description 15
- 238000005303 weighing Methods 0.000 claims abstract description 8
- 238000007789 sealing Methods 0.000 claims abstract description 3
- 229940079593 drug Drugs 0.000 claims description 15
- 239000000463 material Substances 0.000 claims description 14
- 241000237903 Hirudo Species 0.000 claims description 13
- 241000522620 Scorpio Species 0.000 claims description 13
- 239000009490 scorpio Substances 0.000 claims description 13
- 238000000034 method Methods 0.000 claims description 12
- 238000004519 manufacturing process Methods 0.000 claims description 11
- 239000004744 fabric Substances 0.000 claims description 2
- 239000011505 plaster Substances 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 26
- 206010041591 Spinal osteoarthritis Diseases 0.000 abstract description 7
- 208000036319 cervical spondylosis Diseases 0.000 abstract description 7
- 208000005801 spondylosis Diseases 0.000 abstract description 7
- 239000008186 active pharmaceutical agent Substances 0.000 abstract 2
- 241000173529 Aconitum napellus Species 0.000 abstract 1
- 241000510667 Conioselinum Species 0.000 abstract 1
- 241000272060 Elapidae Species 0.000 abstract 1
- 241000645104 Hemidactylus platyurus Species 0.000 abstract 1
- 241000545744 Hirudinea Species 0.000 abstract 1
- 244000018716 Impatiens biflora Species 0.000 abstract 1
- 235000015912 Impatiens biflora Nutrition 0.000 abstract 1
- 241001427555 Polyphaga <Blattaria> Species 0.000 abstract 1
- 241000239226 Scorpiones Species 0.000 abstract 1
- 235000005155 Tanacetum balsamita Nutrition 0.000 abstract 1
- 206010025005 lumbar spinal stenosis Diseases 0.000 abstract 1
- 239000002994 raw material Substances 0.000 abstract 1
- 206010039073 rheumatoid arthritis Diseases 0.000 abstract 1
- 208000005198 spinal stenosis Diseases 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 description 11
- 210000004185 liver Anatomy 0.000 description 9
- 210000004369 blood Anatomy 0.000 description 7
- 239000008280 blood Substances 0.000 description 7
- 241000721047 Danaus plexippus Species 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 231100000614 poison Toxicity 0.000 description 4
- 230000007096 poisonous effect Effects 0.000 description 4
- 241001489978 Eupolyphaga Species 0.000 description 3
- 230000000202 analgesic effect Effects 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 241001312741 Gekko swinhonis Species 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 231100000915 pathological change Toxicity 0.000 description 2
- 230000036285 pathological change Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 241000271039 Agkistrodon Species 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 241000221079 Euphorbia <genus> Species 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 208000002513 Flank pain Diseases 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- 102000009571 Macrophage Inflammatory Proteins Human genes 0.000 description 1
- 108010009474 Macrophage Inflammatory Proteins Proteins 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000031481 Pathologic Constriction Diseases 0.000 description 1
- 241000434639 Speranskia tuberculata Species 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000000146 antalgic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000003164 cauda equina Anatomy 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 210000004969 inflammatory cell Anatomy 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 210000003041 ligament Anatomy 0.000 description 1
- 210000004705 lumbosacral region Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000036262 stenosis Effects 0.000 description 1
- 208000037804 stenosis Diseases 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 231100000925 very toxic Toxicity 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention discloses a medicament for treating prolapse of lumbar intervertebral disc, hyperosteogeny and hydrarthrosis and a preparation method thereof. The medicament is prepared from the following raw materials in parts by weight: 10-25 parts of scorpion, 7-25 parts of leech, 5-18 parts of little multibanded krait, 7-24 parts of Chinese polyphaga, 10-28 parts of Cosymbotus platyurus, 30-55 parts of garden balsam stem, 30-55 parts of hemlock parsley, 30-55 parts of kusnezoff monkshood and 30-55 parts of radix achyranthis bidentatae. The preparation method of the medicament comprises the following steps: (1) weighing the active pharmaceutical ingredients according to the parts by weight; (2) baking the active pharmaceutical ingredients, crushing into powder, and thoroughly mixing; and (3) quickly placing the mixture obtained in the step (2) into a sealing bag. The medicament disclosed by the invention is mainly applicable to prolapse of lumbar intervertebral disc, hyperosteogeny, hydrarthrosis, cervical spondylosis and lumbar spinal stenosis, and has good treatment effects on rheumatism and rheumatoid arthritis.
Description
Technical field
The present invention relates to a kind of Chinese medicine and preparation method thereof, relate in particular to a kind of treatment prolapse of lumbar intervertebral disc, hyperosteogeny, hydrarthrodial medicine and preparation method thereof.
Background technology
Diseases such as prolapse of lumbar intervertebral disc, hyperosteogeny, hydrarthrosis are a frequently-occurring disease, commonly encountered diseases, and by endogenous cause of ill and many exopathogenic factors of the pathological changes that self wears out, for example external force damage, faulty posture cause.This type disease is pathological changes at the skeleton place, the treatment difficulty, and the medicine on the market is a lot, and the medication cycle is long, and the pain in the time of can only alleviating morbidity usually can not be eliminated focus.
Summary of the invention
Problem to be solved by this invention provides a kind of treatment prolapse of lumbar intervertebral disc, hyperosteogeny, hydrarthrodial medicine and preparation method thereof, can effectively treat prolapse of lumbar intervertebral disc, all kinds of hyperosteogeny, hydrarthrosis, and treatment time is short, and healing effect is good.
Problem to be solved by this invention realizes through following technical scheme:
A kind of treatment prolapse of lumbar intervertebral disc, hyperosteogeny, hydrarthrodial medicine are formed by following weight portion feedstock production: Scorpio 10-25, Hirudo 7-25, Serpentis 5-18, eupolyphoge sinensis 7-24, gecko 10-28, Herba speranskiae tuberculatae 30-55, Rhizoma Chuanxiong 30-55, Radix Aconiti Kusnezoffii 30-55, Radix Achyranthis Bidentatae 30-55.
Described treatment prolapse of lumbar intervertebral disc, hyperosteogeny, hydrarthrodial medicine are formed by following weight portion feedstock production: Scorpio 13-22, Hirudo 10-20, Serpentis 8-15, eupolyphoge sinensis 10-20, gecko 13-23, Herba speranskiae tuberculatae 35-45, Rhizoma Chuanxiong 35-45, Radix Aconiti Kusnezoffii 35-45, Radix Achyranthis Bidentatae 35-45.
Described treatment prolapse of lumbar intervertebral disc, hyperosteogeny, hydrarthrodial medicine are formed by following weight portion feedstock production: Scorpio 18, Hirudo 15, Serpentis 12, eupolyphoge sinensis 15, gecko 18, Herba speranskiae tuberculatae 42, Rhizoma Chuanxiong 42, Radix Aconiti Kusnezoffii 42, Radix Achyranthis Bidentatae 42.
Said medicine is prepared into powder.
The method for preparing of above-mentioned treatment prolapse of lumbar intervertebral disc, hyperosteogeny, hydrarthrodial medicine may further comprise the steps:
(1) takes by weighing each raw medicinal material by above-mentioned weight portion;
(2) above-mentioned each raw medicinal material is dried, is ground into powder, fully mix;
(3) mixture in the step (2) is placed sealing bag fast.
Said step (2) Chinese crude drug is crushed to the 100-200 order.
Said medication preparation becomes powder.
The powder that said medication preparation becomes places on the plaster cloth, processes patch.
The effect of said various medical materials is selected for use as follows:
Serpentis: another name Agkistrodon, Serpentis, Flos Chrysanthemi Serpentis; Nature and flavor are sweet, salty, warm; Return liver, kidney channel; Has the wind of searching dehumidifying, dredge the meridian passage, the effect of pain relieving arresting convulsion.
Scorpio: property is hot, flat, poisonous, returns Liver Channel; Effect with endogenous wind stopping spasmolytic, dispersing pathogen accumulation, removing obstruction in the collateral to relieve pain.
Hirudo: the salty hardship of property, flat, slightly poisonous, be included into Liver Channel; The effect of have removing blood stasis, removing blood stasis, stimulating the menstrual flow.
Eupolyphoge sinensis: also claim Eupolyphaga Seu Steleophaga, Eupolyphaga Seu Steleophaga, eupolyphaga, nature and flavor are salty, cold, slightly poisonous; Return Liver Channel; Has removing blood stasis with potent drugs blood, the effect of reuniting the fractured tendons and bones.
Gecko is also claimed Gekko Swinhonis, Gekko Swinhonis, and property is salty, cold, slightly poisonous; Have and dispel the wind, active, the effect of eliminating stagnation.
Radix Aconiti Kusnezoffii: acrid in the mouth, hardship, heat, very toxic; GUIXIN, liver,kidney,spleen warp; Expelling wind and removing dampness is arranged, the effect of antalgic.
Radix Achyranthis Bidentatae: nature and flavor are bitter, acid, flat, go into the Liver and kidney warp; Effect with invigorating the liver and kidney, bone and muscle strengthening, eliminating blood stasis and inducing menstruation, conducting blood to flow downwards.
Herba speranskiae tuberculatae: be the herb of euphorbia plant speranskia tuberculata, nature and flavor are bitter, hot, temperature; Be included into lung, liver two warps; Has expelling wind and removing dampness, detoxifcation analgesic effect.
Rhizoma Chuanxiong: the hot temperature of property, go into liver, gallbladder, pericardium channel; Effect with blood-activating and qi-promoting, wind-expelling pain-stopping.
The monarch compatibility and the synergism of medicine of the present invention are following:
This formula and prescription is rigorous; Take into full account the reasonably combined of monarch medicine; Can bring into play active, the eliminating stagnation effect of monarch drug Scorpio, Hirudo, Serpentis, eupolyphoge sinensis and gecko, strengthen promoting the circulation of blood, bone and muscle strengthening effect with the ministerial drug Radix Achyranthis Bidentatae again, make the monarch drug property of medicine with cure mainly function and strengthen; Again with the expelling wind and removing dampness of adjuvant drug Radix Aconiti Kusnezoffii, Herba speranskiae tuberculatae and messenger drug Rhizoma Chuanxiong, the important effect that the analgesic effect increases this prescription.
Drug main of the present invention will be applicable under prolapse of lumbar intervertebral disc, hyperosteogeny, hydrarthrosis, cervical spondylosis, the lumbar vertebra pipe narrow, and rheumatism and rheumatoid are also had better curative effect.
For proving above-mentioned advantage, medicine of the present invention has carried out the clinical verification with the patch among the embodiment 1, and curative effect is apparent in view.
Clinical trial result is analyzed:
This test portion adopts single center, parallel, open trial, goes into to organize narrow patient's 1546 examples under prolapse of lumbar intervertebral disc, hyperosteogeny, hydrarthrosis, cervical spondylosis, the lumbar vertebra pipe altogether, accomplishes 1546 examples, and 0 example that comes off is rejected 0 example; There are 1546 routine patients to try out patch and carried out efficiency evaluation; Prolapse of lumbar intervertebral disc 380 examples wherein, male's 210 examples, women's 170 examples; Hyperosteogeny 392 examples, male's 152 examples, women's 240 examples; Hydrarthrosis 290 examples, male's 170 examples, women's 120 examples, cervical spondylosis 310 examples, male's 127 examples, women's 183 examples, narrow 174 examples under the lumbar vertebra pipe, male's 74 examples, women's 100 examples.
Clinical symptoms and sign: prolapse of lumbar intervertebral disc 380 routine patients mainly show as flank pain; Its pain scope mainly is at waist and lumbosacral region, and is the most common with persistent dull pain, and pain can alleviate during horizontal position; When erect position and seat, this pain can increase the weight of; Hyperosteogeny 392 routine patients mainly show as pain, swelling, limbs disturbance; The swelling of the main performance of hydrarthrosis 290 example arthremia, pain is oozed out and is increased, hydrarthrosis, the activity difficulty of squatting down, function limitation; Cervical spondylosis 310 examples mainly show vertebra joint unstability, loosening, and vertebral pulp is outstanding or deviate from bony spur formation, the spinal canal stenosis of ligament plumpness and secondary etc.; Narrow patient's 174 examples show as the compressing cauda equina nerve under the lumbar vertebra pipe, numbness, the twinge of perineal position occur, urinate, defecation inability.
Usage and dosage: during treatment patch is applied in the affected part, the next day, change dressings 1 time, and one month is a course of treatment.
Therapeutic outcome: prolapse of lumbar intervertebral disc 380 routine patient treatment 2-3 all took an evident turn for the better after the course of treatment, and are without any side effects, treat 4-5 course cure rate more than 98%.Hyperosteogeny 392 routine patient treatment 2-3 all took an evident turn for the better after the course of treatment, and are without any side effects, treat 4-5 course cure rate more than 98%.Hydrarthrosis 290 routine patient treatment 2-3 all took an evident turn for the better after the course of treatment, and are without any side effects, treat 4-5 course cure rate more than 97%.Cervical spondylosis 310 routine patient treatment 2-3 all took an evident turn for the better after the course of treatment, and are without any side effects, treat 4-5 course cure rate more than 98%.Narrow patient 174 routine patient treatment 2-3 all took an evident turn for the better after the course of treatment under the lumbar vertebra pipe, and are without any side effects, treat 4-5 course cure rate more than 96%.
This medicine also has curative effect preferably to rheumatism and rheumatoid, all takes an evident turn for the better after treating 3 courses of treatment, and is without any side effects, treats 5-6 course cure rate more than 80%.
The pharmacology of medicine of the present invention proves; Said medicine effectively infiltrates through the skeleton place in affected part; To phenomenons such as surrounding tissue edema, fibrin deposition, a large amount of inflammatory cell infiltration, MCP, macrophage inflammatory proteins; Carry out effective inhibition, had the effect of antiinflammatory and analgesic.
Therapeutic outcome shows that this medical instrument has channels sootheing and network vessel quickening, blood circulation and promoting silt, the effect of reducing swelling and alleviating pain; Has a splendid curative effect to narrow under prolapse of lumbar intervertebral disc, hyperosteogeny, hydrarthrosis, cervical spondylosis, the lumbar vertebra pipe.
The specific embodiment
Embodiment 1
A kind of treatment prolapse of lumbar intervertebral disc, hyperosteogeny, hydrarthrodial medicine are formed by following weight portion (kg) feedstock production: Scorpio 18, Hirudo 15, Serpentis 12, eupolyphoge sinensis 15, gecko 18, Herba speranskiae tuberculatae 42, Rhizoma Chuanxiong 42, Radix Aconiti Kusnezoffii 42, Radix Achyranthis Bidentatae 42.
The method for preparing of above-mentioned treatment prolapse of lumbar intervertebral disc, hyperosteogeny, hydrarthrodial medicine may further comprise the steps:
(1) takes by weighing each raw medicinal material by above-mentioned weight portion;
(2) above-mentioned each raw medicinal material is dried, is ground into powder, fully mix;
(3) mixture in the step (2) is crushed to 200 orders, is prepared as patch.
Embodiment 2
A kind of treatment prolapse of lumbar intervertebral disc, hyperosteogeny, hydrarthrodial medicine are formed by following weight portion (kg) feedstock production: Scorpio 13, Hirudo 10, Serpentis 8, eupolyphoge sinensis 10, gecko 13, Herba speranskiae tuberculatae 35, Rhizoma Chuanxiong 35, Radix Aconiti Kusnezoffii 35, Radix Achyranthis Bidentatae 35.
The method for preparing of above-mentioned treatment prolapse of lumbar intervertebral disc, hyperosteogeny, hydrarthrodial medicine may further comprise the steps:
(1) takes by weighing each raw medicinal material by above-mentioned weight portion;
(2) above-mentioned each raw medicinal material is dried, is ground into powder, fully mix;
(3) mixture in the step (2) is crushed to 200 orders, is prepared as patch.
Embodiment 3
A kind of treatment prolapse of lumbar intervertebral disc, hyperosteogeny, hydrarthrodial medicine are formed by following weight portion (kg) feedstock production: Scorpio 22, Hirudo 20, Serpentis 15, eupolyphoge sinensis 20, gecko 23, Herba speranskiae tuberculatae 45, Rhizoma Chuanxiong 45, Radix Aconiti Kusnezoffii 45, Radix Achyranthis Bidentatae 45.
The method for preparing of above-mentioned treatment prolapse of lumbar intervertebral disc, hyperosteogeny, hydrarthrodial medicine may further comprise the steps:
(1) takes by weighing each raw medicinal material by above-mentioned weight portion;
(2) above-mentioned each raw medicinal material is dried, is ground into powder, fully mix;
(3) mixture in the step (2) is crushed to 120 orders, is prepared as powder.
Embodiment 4
A kind of treatment prolapse of lumbar intervertebral disc, hyperosteogeny, hydrarthrodial medicine are formed by following weight portion (kg) feedstock production: Scorpio 10, Hirudo 7, Serpentis 5, eupolyphoge sinensis 7, gecko 10, Herba speranskiae tuberculatae 30, Rhizoma Chuanxiong 30, Radix Aconiti Kusnezoffii 30, Radix Achyranthis Bidentatae 30.
The method for preparing of above-mentioned treatment prolapse of lumbar intervertebral disc, hyperosteogeny, hydrarthrodial medicine may further comprise the steps:
(1) takes by weighing each raw medicinal material by above-mentioned weight portion;
(2) above-mentioned each raw medicinal material is dried, is ground into powder, fully mix;
(3) mixture in the step (2) is crushed to 180 orders, is prepared as patch.
Embodiment 5
A kind of treatment prolapse of lumbar intervertebral disc, hyperosteogeny, hydrarthrodial medicine are formed by following weight portion (kg) feedstock production: Scorpio 25, Hirudo 25, Serpentis 18, eupolyphoge sinensis 24, gecko 28, Herba speranskiae tuberculatae 55, Rhizoma Chuanxiong 55, Radix Aconiti Kusnezoffii 55, Radix Achyranthis Bidentatae 55.
The method for preparing of above-mentioned treatment prolapse of lumbar intervertebral disc, hyperosteogeny, hydrarthrodial medicine may further comprise the steps:
(1) takes by weighing each raw medicinal material by above-mentioned weight portion;
(2) above-mentioned each raw medicinal material is dried, is ground into powder, fully mix;
(3) mixture in the step (2) is crushed to 200 orders, is prepared as patch.
Claims (8)
1. treat prolapse of lumbar intervertebral disc, hyperosteogeny, hydrarthrodial medicine for one kind, form by following weight portion feedstock production: Scorpio 10-25, Hirudo 7-25, Serpentis 5-18, eupolyphoge sinensis 7-24, gecko 10-28, Herba speranskiae tuberculatae 30-55, Rhizoma Chuanxiong 30-55, Radix Aconiti Kusnezoffii 30-55, Radix Achyranthis Bidentatae 30-55.
2. treatment prolapse of lumbar intervertebral disc according to claim 1, hyperosteogeny, hydrarthrodial medicine are formed by following weight portion feedstock production: Scorpio 13-22, Hirudo 10-20, Serpentis 8-15, eupolyphoge sinensis 10-20, gecko 13-23, Herba speranskiae tuberculatae 35-45, Rhizoma Chuanxiong 35-45, Radix Aconiti Kusnezoffii 35-45, Radix Achyranthis Bidentatae 35-45.
3. treatment prolapse of lumbar intervertebral disc according to claim 1, hyperosteogeny, hydrarthrodial medicine are formed by following weight portion feedstock production: Scorpio 18, Hirudo 15, Serpentis 12, eupolyphoge sinensis 15, gecko 18, Herba speranskiae tuberculatae 42, Rhizoma Chuanxiong 42, Radix Aconiti Kusnezoffii 42, Radix Achyranthis Bidentatae 42.
4. according to the described treatment prolapse of lumbar intervertebral disc of one of claim 1-3, hyperosteogeny, hydrarthrodial medicine, said medication preparation becomes powder or patch.
5. according to the method for preparing of the described treatment prolapse of lumbar intervertebral disc of one of claim 1-3, hyperosteogeny, hydrarthrodial medicine, may further comprise the steps:
(1) takes by weighing each raw medicinal material by the weight portion among one of claim 1-3;
(2) above-mentioned each raw medicinal material is dried, is ground into powder, fully mix;
(3) mixture in the step (2) is placed sealing bag fast.
6. the method for preparing of treatment prolapse of lumbar intervertebral disc according to claim 5, hyperosteogeny, hydrarthrodial medicine, said step (2) Chinese crude drug is crushed to the 100-200 order.
7. the method for preparing of treatment prolapse of lumbar intervertebral disc according to claim 5, hyperosteogeny, hydrarthrodial medicine, said medication preparation becomes powder.
8. the method for preparing of treatment prolapse of lumbar intervertebral disc according to claim 7, hyperosteogeny, hydrarthrodial medicine, the powder that said medication preparation becomes places on the plaster cloth, processes patch.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201110331039.8A CN102370731B (en) | 2011-10-27 | 2011-10-27 | Medicament for treating prolapse of lumbar intervertebral disc, hyperosteogeny and hydrarthrosis and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201110331039.8A CN102370731B (en) | 2011-10-27 | 2011-10-27 | Medicament for treating prolapse of lumbar intervertebral disc, hyperosteogeny and hydrarthrosis and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102370731A true CN102370731A (en) | 2012-03-14 |
| CN102370731B CN102370731B (en) | 2014-01-29 |
Family
ID=45790315
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201110331039.8A Active CN102370731B (en) | 2011-10-27 | 2011-10-27 | Medicament for treating prolapse of lumbar intervertebral disc, hyperosteogeny and hydrarthrosis and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102370731B (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103565896A (en) * | 2013-11-25 | 2014-02-12 | 宋文学 | Elaphe moellendorffi-contained medicated wine |
| CN104257961A (en) * | 2014-10-17 | 2015-01-07 | 罗伟汉 | Dressing for treating neck shoulder waist and leg pain, slipped disc and rheumatoid hyperplasia and preparation method of dressing |
| CN107412491A (en) * | 2017-08-24 | 2017-12-01 | 石玉芹 | A kind of externally applied ointment for treating hyperosteogeny patch and preparation method thereof |
| CN110051767A (en) * | 2019-05-08 | 2019-07-26 | 汤合燕 | A kind of external medicinal liquid and preparation method thereof with blood circulation invigorating efficacies |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1172666A (en) * | 1997-08-15 | 1998-02-11 | 刘福印 | Medicine for treating osteoporosis and its preparing method |
| CN1278446A (en) * | 1999-06-18 | 2001-01-03 | 贺云青 | Chinese medicinal composition for cerebrovascular disease, rheumatism and rheumatoid disease |
| CN1304760A (en) * | 2000-12-14 | 2001-07-25 | 惠留义 | Plaster for treating ostalgia and its preparing process |
| CN1640440A (en) * | 2004-01-12 | 2005-07-20 | 张金学 | External-use Chinese medicine for treating osteoproliferation and its preparing method |
| CN101502615A (en) * | 2009-02-10 | 2009-08-12 | 温志民 | Plaster for traumatic injury and bone fracture |
-
2011
- 2011-10-27 CN CN201110331039.8A patent/CN102370731B/en active Active
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1172666A (en) * | 1997-08-15 | 1998-02-11 | 刘福印 | Medicine for treating osteoporosis and its preparing method |
| CN1278446A (en) * | 1999-06-18 | 2001-01-03 | 贺云青 | Chinese medicinal composition for cerebrovascular disease, rheumatism and rheumatoid disease |
| CN1304760A (en) * | 2000-12-14 | 2001-07-25 | 惠留义 | Plaster for treating ostalgia and its preparing process |
| CN1640440A (en) * | 2004-01-12 | 2005-07-20 | 张金学 | External-use Chinese medicine for treating osteoproliferation and its preparing method |
| CN101502615A (en) * | 2009-02-10 | 2009-08-12 | 温志民 | Plaster for traumatic injury and bone fracture |
Non-Patent Citations (2)
| Title |
|---|
| 宋建忠，主编: "《偏方秘方大全》", 31 December 2008, article "壁虎散治骨质增生", pages: 124 * |
| 路德华，等主编: "《痛证的中医疗法》", 31 December 1998, article "六虫散", pages: 445 * |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103565896A (en) * | 2013-11-25 | 2014-02-12 | 宋文学 | Elaphe moellendorffi-contained medicated wine |
| CN104257961A (en) * | 2014-10-17 | 2015-01-07 | 罗伟汉 | Dressing for treating neck shoulder waist and leg pain, slipped disc and rheumatoid hyperplasia and preparation method of dressing |
| CN107412491A (en) * | 2017-08-24 | 2017-12-01 | 石玉芹 | A kind of externally applied ointment for treating hyperosteogeny patch and preparation method thereof |
| CN110051767A (en) * | 2019-05-08 | 2019-07-26 | 汤合燕 | A kind of external medicinal liquid and preparation method thereof with blood circulation invigorating efficacies |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102370731B (en) | 2014-01-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102178894B (en) | Plaster and preparation method of plaster | |
| CN102125672A (en) | Traditional Chinese medicine for treating cervical and lumbar spinal diseases and preparation method thereof | |
| CN102370731B (en) | Medicament for treating prolapse of lumbar intervertebral disc, hyperosteogeny and hydrarthrosis and preparation method thereof | |
| CN104324093B (en) | A kind of Chinese medicine composition treating hyperosteogeny and preparation method thereof | |
| CN104027462B (en) | A kind of Chinese medicine preparation for the treatment of osteoarthritis and preparation method thereof | |
| CN103263601B (en) | Chinese herbal preparation for accelerating fracture post-operation healing and preparation method of Chinese herbal preparation | |
| CN104721426A (en) | Traditional Chinese medicine composition for promoting fracture healing | |
| CN106309954A (en) | Plaster for treating osteopathy | |
| CN103463261B (en) | Traditional Chinese medicine preparation for treating lumbar intervertebral disc herniation | |
| CN105709074A (en) | Medicine for treating rheumatic arthritis and hyperostosis and preparation method | |
| CN104474108A (en) | Traditional Chinese medicine preparation for treating acute appendicitis and preparation method of traditional Chinese medicine preparation | |
| CN106511905A (en) | Traditional Chinese medicine preparation used for curing cervical spondylosis and preparation method thereof | |
| CN103585294B (en) | A kind of for plaster treating hyperosteogeny and preparation method thereof | |
| CN103055105B (en) | Chinese medicinal herb composition for treating orthopedic diseases and preparation method thereof | |
| CN101797291B (en) | Traditional Chinese medicine for treating osteoproliferation | |
| CN105456509A (en) | Plaster for treating spondylodynia and preparation method thereof | |
| CN105311210A (en) | Pharmaceutical composition for treating rheumatoid bone diseases | |
| CN104873699A (en) | Traditional Chinese medicine ointment and preparation method thereof | |
| CN104352737A (en) | Traditional Chinese medicinal preparation for treating rheumatic low back and leg pain | |
| CN104173516B (en) | A kind of combination medicine being used for the treatment of traumatic injury and preparation method thereof | |
| CN101843886A (en) | Medicine containing saussurea and for curing rheumatic bone disease and preparation method thereof | |
| CN102579613A (en) | Oral Chinese medicinal composition for treating rheumatism pain | |
| CN100353995C (en) | Pharmaceutical composition with functions of dispersing pathogenic wind, activating collaterals ,and clearing away toxin | |
| CN106138415A (en) | A kind of Chinese medicine composition of the femur head necrosis caused for a variety of causes | |
| CN106139042A (en) | A kind of new medicine composition treating cervical spondylopathy and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| ASS | Succession or assignment of patent right |
Owner name: NIU GAOFENG Effective date: 20131128 Owner name: JIANG YONGLAN Free format text: FORMER OWNER: NIU GAOFENG Effective date: 20131128 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20131128 Address after: 264499, room 3, unit 72, building 306, Hengshan Road, Shandong, Wendeng, China Applicant after: Jiang Yonglan Applicant after: Niu Gaofeng Address before: 302, room 25-1, 264499 Heng Shan Road, Shandong, Wendeng Applicant before: Niu Gaofeng |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| DD01 | Delivery of document by public notice |
Addressee: Niu Gaofeng Document name: Notice of examination and approval of fee reduction |
|
| DD01 | Delivery of document by public notice |